Acinetobacter baumannii: an emerging opportunistic pathogen
- PMID: 22546906
- PMCID: PMC3442836
- DOI: 10.4161/viru.19700
Acinetobacter baumannii: an emerging opportunistic pathogen
Abstract
Acinetobacter baumannii is an opportunistic bacterial pathogen primarily associated with hospital-acquired infections. The recent increase in incidence, largely associated with infected combat troops returning from conflict zones, coupled with a dramatic increase in the incidence of multidrug-resistant (MDR) strains, has significantly raised the profile of this emerging opportunistic pathogen. Herein, we provide an overview of the pathogen, discuss some of the major factors that have led to its clinical prominence and outline some of the novel therapeutic strategies currently in development.
Figures
Similar articles
-
[Acinetobacter baumannii. An opportunistic pathogen offside?].Med Clin (Barc). 2012 Mar 3;138(5):204-6. doi: 10.1016/j.medcli.2011.09.023. Epub 2011 Nov 8. Med Clin (Barc). 2012. PMID: 22075229 Spanish. No abstract available.
-
Extreme drug resistance in Acinetobacter baumannii infections in intensive care units, South Korea.Emerg Infect Dis. 2009 Aug;15(8):1325-7. doi: 10.3201/eid1508.080772. Emerg Infect Dis. 2009. PMID: 19751609 Free PMC article. No abstract available.
-
Acinetobacter baumannii: an emerging multidrug-resistant threat.Expert Rev Anti Infect Ther. 2008 Jun;6(3):309-25. doi: 10.1586/14787210.6.3.309. Expert Rev Anti Infect Ther. 2008. PMID: 18588496 Review.
-
Are we closing in on an "elusive enemy"? The current status of our battle with Acinetobacter baumannii.Virulence. 2011 Mar-Apr;2(2):86-90. doi: 10.4161/viru.2.2.15748. Virulence. 2011. PMID: 21499025 No abstract available.
-
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.Nat Rev Microbiol. 2007 Dec;5(12):939-51. doi: 10.1038/nrmicro1789. Nat Rev Microbiol. 2007. PMID: 18007677 Review.
Cited by
-
Discovery of a Monoclonal Antibody That Targets Cell-Surface Pseudaminic Acid of Acinetobacter baumannii with Direct Bactericidal Effect.ACS Cent Sci. 2024 Feb 7;10(2):439-446. doi: 10.1021/acscentsci.3c01507. eCollection 2024 Feb 28. ACS Cent Sci. 2024. PMID: 38435534 Free PMC article.
-
Genomic Characterization of Mobile Genetic Elements Associated with Multidrug-Resistant Acinetobacter Non-baumannii Species from Southern Thailand.Antibiotics (Basel). 2024 Feb 2;13(2):149. doi: 10.3390/antibiotics13020149. Antibiotics (Basel). 2024. PMID: 38391535 Free PMC article.
-
Treatment and Management of Acinetobacter Pneumonia: Lessons Learned from Recent World Event.Infect Drug Resist. 2024 Feb 8;17:507-529. doi: 10.2147/IDR.S431525. eCollection 2024. Infect Drug Resist. 2024. PMID: 38348231 Free PMC article. Review.
-
GATR-3, a Peptide That Eradicates Preformed Biofilms of Multidrug-Resistant Acinetobacter baumannii.Antibiotics (Basel). 2023 Dec 31;13(1):39. doi: 10.3390/antibiotics13010039. Antibiotics (Basel). 2023. PMID: 38247598 Free PMC article.
-
Epidemiology and antimicrobial resistance trends of Acinetobacter species in the United Arab Emirates: a retrospective analysis of 12 years of national AMR surveillance data.Front Public Health. 2024 Jan 4;11:1245131. doi: 10.3389/fpubh.2023.1245131. eCollection 2023. Front Public Health. 2024. PMID: 38239785 Free PMC article.
References
-
- Montefour K, Frieden J, Hurst S, Helmich C, Headley D, Martin M, et al. Acinetobacter baumannii: an emerging multidrug-resistant pathogen in critical care. Crit Care Nurse. 2008;28:15–25, quiz 26. - PubMed
-
- Turton JF, Kaufmann ME, Gill MJ, Pike R, Scott PT, Fishbain J, et al. Comparison of Acinetobacter baumannii isolates from the United Kingdom and the United States that were associated with repatriated casualties of the Iraq conflict. J Clin Microbiol. 2006;44:2630–4. doi: 10.1128/JCM.00547-06. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
